About Albert David Ltd
Data last updated: 26 September 2026
Albert David Ltd is a public limited company based in Kolkata, West Bengal, India. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 16 November 1938, the company has been in operation for over 88 years.
Registered with ROC Kolkata under CIN L51109WB1938PLC009490. Listed on BSE: 524075 and NSE: ALBERTDAVD.
Capital: an authorised share capital of ₹10 Cr and a paid-up capital of ₹5.71 Cr. It is led by directors including Arun Kumar Kothari and Prabhawati Devi Kothari.
Last AGM: 02 August 2025. Financial statements filed for year ended 31 March 2025. Office: 'D' Block 3Rd Floor Gillander House Netaji Subhas Road, Kolkata, West Bengal, India – 700001.
As per the latest standalone financials for FY 2025-26, the company reported a revenue of ₹333.6 Cr, a decline of 3.52% compared to the previous year. The net worth stands at ₹391.54 Cr (down 0.24% YoY). Total assets are valued at ₹427.86 Cr (up 3.87% YoY).
The company has a workforce of approximately 1,344 employees as per the latest available data.
The company is associated with 1 brand - Albert David India. As per MCA filings, the company has open charges of ₹56 Cr and satisfied charges of ₹43 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website albertdavidindia.com.
-
EmailLocked
-
TelephoneLocked
-
Website
-
Social MediaLocked
-
Registered Address'D' Block 3Rd Floor Gillander House Netaji Subhas Road, Kolkata, West Bengal, India – 700001
-
IndustryPharma, Drug Formulation & Development
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
CIN History of Albert David Ltd
Albert David Ltd has one previous CIN (Corporate Identification Number): U51109WB1938PLC009490. The current CIN is L51109WB1938PLC009490, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L51109WB1938PLC009490 | Current |
| U51109WB1938PLC009490 | Previous |
Associated Brands with Albert David Ltd
Albert David Ltd operates one associated brand: Albert David India. These brands represent Albert David Ltd's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical formulations, infusions, and syringes are manufactured. | albertdavidindia.com |
Competitors & Alternatives of Albert David Ltd
Brands and companies operating in the same space as Albert David Ltd include Merck, Roivant Sciences, AbbVie and 7 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
Merck
|
Pharmaceutical products are manufactured and marketed worldwide. | Kenilworth, United Kingdom, United Kingdom | 1891 |
Roivant Sciences
|
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | New York, United States, United States | 2014 |
AbbVie
|
Biopharmaceutical research and drug development are conducted globally by AbbVie. | Chicago, United States, United States | 2012 |
Lilly
|
Traditional pharmaceutical medicines are developed for multiple health fields. | United States | 1876 |
Gilead
|
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | Foster City, United States, United States | 1987 |
United Therapeutics
|
Treatments for chronic and life-threatening diseases are developed and commercialized. | Silver Spring, United States, United States | 1998 |
Roche
|
Pharmaceuticals and diagnostics kits are developed for various diseases. | Basel, Switzerland, Switzerland | 1896 |
Ascendis Pharma
|
Long-acting prodrug therapies are developed for endocrine and rare diseases. | Hellerup, Denmark, Denmark | 2007 |
MorphoSys
|
Therapeutic antibodies for cancer and other diseases are developed. | Planegg, Germany, Germany | 1992 |
Vertex Pharmaceuticals
|
Developer of drugs for the treatment of multiple disorders | United States | 1989 |
Business Activity of Albert David Ltd
Albert David Ltd is engaged in principal business activities including manufacturing and trade, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products, wholesale trading. The company has 2 registered principal business activity segments, demonstrating its operational diversity and market reach.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details for Albert David Ltd
Turnover contribution percentages and historical activity changes require an active report plan.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of Albert David Ltd
Albert David Ltd is audited by L. B. Jha & Co. for the financial year 2023. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| L. B. Jha & Co. | Locked | Locked | Locked |
Complete auditor history for Albert David Ltd
Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Albert David Ltd
Albert David Ltd is currently managed by 9 directors, with 19 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
|
Arun Kumar Kothari
Also directs:
Albert David Ltd, Gillanders Arbuthnot & Co Ltd, Bharat Fritz Werner Limited and 5 more
|
Whole-Time Director | 20 Jun 1988 | 38 Years 3 Months | Current |
|
Prabhawati Devi Kothari
Also directs:
Albert David Ltd, Gillanders Arbuthnot & Co Ltd, Bharat Fritz Werner Limited and 2 more
|
Director | 31 Mar 2014 | 12 Years 5 Months | Current |
|
Monjori Mitra
Also directs:
Albert David Ltd, Tarsons Products Limited, Strategic Marketing Solutions And Research Centre Private Limited and 1 more
|
Director | 24 Aug 2020 | 6 Years 1 Months | Current |
|
Anand Vardhan Kothari
Also directs:
Albert David Ltd, Bharat Fritz Werner Limited, Shubh Ananda Advisory Private Limited and 2 more
|
Director | 11 May 2022 | 4 Years 4 Months | Current |
| Rajiv Anant Desai | Director | 02 Aug 2025 | 1 Years 1 Months | Current |
| Naresh Pachisia | Director | 14 Nov 2024 | 1 Years 10 Months | Current |
Financials of Albert David Ltd FY 2025-26 filings available
Albert David Ltd reported revenue of ₹333.6 Cr (down 3.52% YoY) for FY 2025-26.
Financial Highlights
FY 2025-26 · StandaloneRevenue vs Net Profit ₹ Cr
Margin trends
Financial summary ₹ Cr
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 334 | 346 | 362 | 342 | 314 | 247 | 321 |
| Revenue growth | -4.3% | +8.6% | +6.2% | +9.0% | +19.5% | -21.4% | +1.2% |
| EBITDA | 5.73 | 3.17 | 46.98 | 44.46 | 40.93 | 19.28 | 30.52 |
| EBITDA margin | +1.7% | +0.9% | +13.0% | +13.0% | +13.1% | +7.8% | +9.5% |
| Profit before tax | 0.52 | 25.23 | 97.27 | 50.73 | 47.29 | 27.45 | 28.98 |
| Net profit | (1.72) | 16.86 | 75.40 | 36.16 | 32.88 | 21.40 | 18.97 |
| Net profit margin | -0.5% | +4.9% | +20.8% | +10.6% | +10.5% | +8.7% | +5.9% |
| EPS (₹) | (2.62) | 30.14 | 132.15 | 63.38 | 61.78 | 38.80 | 33.59 |
| Balance sheet | |||||||
| Total assets | 428 | 412 | 398 | 329 | 298 | 261 | 240 |
| Net worth | 392 | 392 | 383 | 312 | 279 | 244 | 223 |
| Total debt | 29.58 | 12.32 | 3.32 | 5.32 | 5.67 | 1.62 | 2.04 |
| Cash & bank | 32.77 | 1.69 | 31.16 | 25.22 | 18.56 | 35.37 | 6.75 |
| Net working capital | 63.15 | 18.63 | 21.01 | 43.22 | (7.09) | 29.79 | 22.91 |
| Cash flow | |||||||
| Cash from operations | (7.66) | (28.44) | 45.50 | 10.52 | 40.36 | 36.61 | 30.25 |
| Cash from investing | (4.38) | 23.30 | (33.24) | (4.98) | (39.62) | (36.68) | (19.92) |
| Cash from financing | 11.92 | 0.11 | (8.27) | (6.36) | (4.88) | (1.71) | (10.33) |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 101 | 85.86 | 89.93 | 87.24 | 70.57 | 74.89 | 83.08 | 98.44 |
| Revenue growth (YoY) | +43.6% | +14.7% | +8.3% | -11.4% | -21.0% | -15.9% | -5.9% | +5.6% |
| Other income | 27.96 | (24.84) | 12.40 | (2.14) | 22.04 | (5.11) | (9.01) | 20.64 |
| Total expenses | 90.70 | 83.11 | 79.10 | 84.70 | 81.22 | 79.64 | 82.41 | 92.21 |
| EBITDA | 10.64 | 2.75 | 10.83 | 2.54 | (10.65) | (4.75) | 0.67 | 6.23 |
| EBITDA margin | +10.5% | +3.2% | +12.0% | +2.9% | -15.1% | -6.3% | +0.8% | +6.3% |
| Depreciation | 2.29 | 2.72 | 2.42 | 2.23 | 2.39 | 1.82 | 1.70 | 1.67 |
| Interest | 0.52 | 0.43 | 0.90 | 0.75 | 0.55 | 0.13 | 0.13 | 0.06 |
| Profit before tax | 35.79 | (25.24) | 19.91 | (2.58) | 8.45 | (11.81) | (10.17) | 25.14 |
| Tax | 3.80 | (3.80) | 4.60 | 0.72 | 0.50 | (1.48) | (0.78) | 7.06 |
Financial Statements
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 101 | 85.86 | 89.93 | 87.24 | 70.57 | 74.89 | 83.08 | 98.44 |
| Revenue growth (YoY) | +43.6% | +14.7% | +8.3% | -11.4% | -21.0% | -15.9% | -5.9% | +5.6% |
| Other income | 27.96 | (24.84) | 12.40 | (2.14) | 22.04 | (5.11) | (9.01) | 20.64 |
| Total expenses | 90.70 | 83.11 | 79.10 | 84.70 | 81.22 | 79.64 | 82.41 | 92.21 |
| EBITDA | 10.64 | 2.75 | 10.83 | 2.54 | (10.65) | (4.75) | 0.67 | 6.23 |
| EBITDA margin | +10.5% | +3.2% | +12.0% | +2.9% | -15.1% | -6.3% | +0.8% | +6.3% |
| Depreciation | 2.29 | 2.72 | 2.42 | 2.23 | 2.39 | 1.82 | 1.70 | 1.67 |
| Interest | 0.52 | 0.43 | 0.90 | 0.75 | 0.55 | 0.13 | 0.13 | 0.06 |
| Profit before tax | 35.79 | (25.24) | 19.91 | (2.58) | 8.45 | (11.81) | (10.17) | 25.14 |
| Tax | 3.80 | (3.80) | 4.60 | 0.72 | 0.50 | (1.48) | (0.78) | 7.06 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Revenue | 334 | 346 | 362 | 342 | 314 | 247 | 321 |
| Revenue growth | -4.3% | +8.6% | +6.2% | +9.0% | +19.5% | -21.4% | +1.2% |
| Other income | 7.45 | 29.58 | 57.55 | 15.40 | 15.84 | 17.18 | 7.11 |
| Total expenses | 328 | 343 | 315 | 297 | 273 | 228 | 290 |
| Employee cost | 102 | 109 | 88.43 | 81.07 | 85.38 | 82.70 | 90.34 |
| EBITDA | 5.73 | 3.17 | 46.98 | 44.46 | 40.93 | 19.28 | 30.52 |
| EBITDA margin | +1.7% | +0.9% | +13.0% | +13.0% | +13.1% | +7.8% | +9.5% |
| Depreciation | 9.76 | 6.97 | 6.83 | 8.55 | 8.81 | 8.23 | 7.67 |
| Interest | 2.90 | 0.55 | 0.43 | 0.58 | 0.67 | 0.78 | 0.98 |
| Profit before tax | 0.52 | 25.23 | 97.27 | 50.73 | 47.29 | 27.45 | 28.98 |
| Tax | 2.01 | 8.02 | 21.87 | 14.56 | 12.04 | 5.30 | 9.79 |
| Net profit | (1.72) | 16.86 | 75.40 | 36.16 | 32.88 | 21.40 | 18.97 |
| Net profit margin | -0.5% | +4.9% | +20.8% | +10.6% | +10.5% | +8.7% | +5.9% |
| EPS (₹) | (2.62) | 30.14 | 132.15 | 63.38 | 61.78 | 38.80 | 33.59 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Equity & liabilities | |||||||
| Share capital | 5.71 | 5.71 | 5.71 | 5.71 | 5.71 | 5.71 | 5.71 |
| Reserves & surplus | 386 | 387 | 377 | 306 | 274 | 239 | 217 |
| Shareholders' funds (net worth) | 392 | 392 | 383 | 312 | 279 | 244 | 223 |
| Secured loans | 28.48 | 10.05 | 2.10 | 3.97 | 3.77 | 0.43 | 1.44 |
| Unsecured loans | 1.10 | 2.27 | 1.22 | 1.35 | 1.90 | 1.19 | 0.60 |
| Total debt | 29.58 | 12.32 | 3.32 | 5.32 | 5.67 | 1.62 | 2.04 |
| Total liabilities | 428 | 412 | 398 | 329 | 298 | 261 | 240 |
| Assets | |||||||
| Gross block | 262 | 253 | 233 | 224 | 224 | 212 | 212 |
| Net block | 99.65 | 98.78 | 83.39 | 80.03 | 87.68 | 83.96 | 91.00 |
| Capital work in progress | 20.77 | 1.92 | 6.74 | 2.72 | 0.81 | 0.75 | 1.52 |
| Investments | 243 | 260 | 273 | 193 | 183 | 138 | 122 |
| Inventories | 58.27 | 63.90 | 43.61 | 50.68 | 39.18 | 35.75 | 42.72 |
| Sundry debtors | 33.92 | 27.37 | 29.33 | 30.33 | 25.07 | 19.49 | 30.13 |
| Cash & bank balances | 32.77 | 1.69 | 31.16 | 25.22 | 18.56 | 35.37 | 6.75 |
| Loans & advances | 24.39 | 18.86 | 13.23 | 31.23 | 14.50 | 18.54 | 23.69 |
| Total current assets | 149 | 112 | 117 | 137 | 97.31 | 109 | 103 |
| Total current liabilities | 86.20 | 93.19 | 96.32 | 94.24 | 104 | 79.36 | 80.38 |
| Net working capital | 63.15 | 18.63 | 21.01 | 43.22 | (7.09) | 29.79 | 22.91 |
| Total assets | 428 | 412 | 398 | 329 | 298 | 261 | 240 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Opening cash | 0.42 | 5.44 | 1.45 | 2.28 | 2.64 | 6.42 | 6.41 |
| Net cash from operating activities | (7.66) | (28.44) | 45.50 | 10.52 | 40.36 | 36.61 | 30.25 |
| Net cash from investing activities | (4.38) | 23.30 | (33.24) | (4.98) | (39.62) | (36.68) | (19.92) |
| Net cash from financing activities | 11.92 | 0.11 | (8.27) | (6.36) | (4.88) | (1.71) | (10.33) |
| Net change in cash | (0.12) | (5.02) | 3.99 | (0.83) | (4.13) | (1.77) | 0.00 |
| Closing cash | 32.77 | 1.69 | 31.16 | 25.22 | 18.56 | 35.37 | 6.75 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| Sales growth | -3.5% | -4.6% | +6.1% | +9.0% | +26.7% | -22.9% | +1.2% |
| EBITDA growth | +80.8% | -93.3% | +5.7% | +8.6% | +112.3% | -36.8% | +2.1% |
| PBT growth | -97.9% | -74.1% | +91.7% | +7.3% | +72.3% | -5.3% | -23.3% |
| Net income growth | - | -77.6% | +108.5% | +10.0% | +53.6% | +12.8% | -29.5% |
| Revenue CAGR (3Y) | -0.8% | +3.3% | +13.6% | +2.1% | -0.4% | -4.9% | +2.8% |
| EBITDA CAGR (3Y) | -49.5% | -57.4% | +34.6% | +13.4% | +11.0% | +1.9% | +4.3% |
| Profitability & leverage | |||||||
| Net income margin | -0.5% | +5.0% | +20.8% | +10.6% | +11.2% | +9.0% | +6.0% |
| Return on capital employed | +0.8% | +6.4% | +26.9% | +16.4% | +17.2% | +11.3% | +12.9% |
| Return on net worth | -0.4% | +4.4% | +21.7% | +12.2% | +13.5% | +9.5% | +8.9% |
| Debt / equity | 0.05 | 0.02 | 0.01 | 0.02 | 0.01 | 0.01 | 0.01 |
| Long-term debt / equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest cover | -71.96 | -14.47 | 1.07 | 1.62 | 2.09 | 7.06 | 4.29 |
| Efficiency & per share | |||||||
| Fixed asset turnover | 1.30 | 1.42 | 1.59 | 1.53 | 1.44 | 1.17 | 1.59 |
| Inventory turnover | 5.46 | 6.43 | 7.69 | 7.60 | 8.37 | 6.31 | 7.39 |
| Debtors turnover | 10.89 | 12.20 | 12.15 | 12.35 | 14.07 | 9.97 | 12.36 |
| EPS (₹) | (2.62) | 30.14 | 132.15 | 63.38 | 61.78 | 38.80 | 33.59 |
| Dividend per share (₹) | 5.00 | 5.00 | 11.50 | 9.00 | 9.00 | 6.00 | 7.00 |
| Book value per share (₹) | 686.04 | 687.70 | 671.05 | 545.93 | 489.68 | 428.20 | 390.38 |
Shareholding Pattern of Albert David Ltd
As per the shareholding pattern for the quarter ended Jun 2026, promoters hold 62.20%, foreign institutional investors hold 0.60%, domestic institutional investors hold 1.60%, retail and other public shareholders hold 35.60% of Albert David Ltd.
| Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | |
|---|---|---|---|---|
| Promoters | 62.20% | 62.20% | 62.20% | 62.20% |
| Public | 37.80% | 37.80% | 37.80% | 37.80% |
Charges & Borrowings of Albert David Ltd
| Date | Lender | Amount | Status |
|---|---|---|---|
| 06 May 2025 | Others | ₹20 Cr | Open |
| 18 May 2004 | State Bank of India | ₹18.5 Cr | Open |
| 17 Jun 1981 | State Bank of India | ₹17.5 Cr | Open |
| 31 Aug 2015 | State Bank of India | ₹35 Cr | Satisfied |
| 13 Jul 2009 | State Bank of India | ₹8 Cr | Satisfied |
Total charge records: 5 View all charges
Employees and EPFO Compliance at Albert David Ltd
Albert David Ltd has a workforce of 1,344 employees as of Apr 07, 2024.
Employee and EPFO history for Albert David Ltd
Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Albert David Ltd
GST registrations and filing compliance for Albert David Ltd
State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Albert David Ltd
Credit ratings, litigation, and regulatory alerts for Albert David Ltd
Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Albert David Ltd
MSME payment history for Albert David Ltd
Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Albert David Ltd
Corporate group structure for Albert David Ltd
Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Albert David Ltd
MCA filings and documents for Albert David Ltd
Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Albert David Ltd
Recent News on Albert David Ltd
Frequently Asked Questions about Albert David Ltd
Albert David Ltd is an active public limited company in the pharma sector based in Kolkata, West Bengal, India. It was incorporated on 16 November 1938 (88+ years old) and is registered under CIN L51109WB1938PLC009490. Listed on BSE: 524075 and NSE: ALBERTDAVD. The company has 1,344 employees.
Albert David Ltd reported revenue of ₹333.6 Cr for FY 2025-26 (down 3.52% YoY) based on standalone financials.
The current directors of Albert David Ltd are:
- Arun Kumar Kothari - Whole-Time Director
- Prabhawati Devi Kothari - Director
- Monjori Mitra - Director
- Anand Vardhan Kothari - Director
- Rajiv Anant Desai - Director
- Naresh Pachisia - Director
- Anurag Singhi - Director
- Shourya Sengupta - Director
- Amit Mahla - Additional Director
The primary industry of Albert David Ltd is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.
Yes. Albert David Ltd is listed on both BSE (code: 524075) and NSE (symbol: ALBERTDAVD).
Albert David Ltd can be reached at the registered office: D Block 3Rd Floor Gillander House Netaji Subhas Road, Kolkata, West Bengal, India – 700001, or through the website albertdavidindia.com.